Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $8.26 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.05.
Market Cap
8.26T
Revenue
4.59T
Profits
201.29B
PE Ratio
41.05
Profit Margin
4.39%
Dividend Yield
0.43%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 965.04B | -2.06% | 2,693,448 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 538.04B | -0.81% | 8,040,998 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 376.20B | -2.20% | 4,858,421 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 344.97B | -0.12% | 6,623,721 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 284.45B | -2.99% | 9,406,728 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 280.17B | -3.21% | 2,892,911 | 60.44B |
| 7 | NVS | Novartis AG | 265.01B | -2.99% | 2,052,759 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 196.40B | -3.31% | 12,978,866 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 183.60B | 0.31% | 3,194,696 | 45.20B |
| 10 | AMGN | Amgen Inc. | 177.63B | -2.27% | 2,120,812 | 37.22B |
| 11 | GILD | Gilead Sciences, Inc. | 162.77B | -2.48% | 6,259,248 | 29.74B |
| 12 | ABT | Abbott Laboratories | 152.90B | 2.55% | 10,557,560 | 45.13B |
| 13 | PFE | Pfizer Inc. | 146.08B | -2.10% | 35,553,597 | 63.32B |
| 14 | ISRG | Intuitive Surgical, Inc. | 146.01B | -2.92% | 3,033,644 | 10.58B |
| 15 | DHR | Danaher Corporation | 127.31B | -1.53% | 3,652,710 | 24.78B |
| 16 | CVS | CVS Health Corporation | 115.62B | -0.40% | 5,153,847 | 405.62B |
| 17 | SYK | Stryker Corporation | 114.80B | -1.85% | 2,950,352 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 112.21B | -3.90% | 20,579,785 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 111.27B | -2.04% | 1,115,282 | 12.22B |
| 20 | SNY | Sanofi | 103.41B | -1.63% | 2,707,249 | 54.60B |
| 21 | GSK | GSK plc | 98.90B | -2.43% | 4,053,457 | 43.29B |
| 22 | MDT | Medtronic plc | 94.98B | 0.23% | 14,209,849 | 35.48B |
| 23 | MCK | McKesson Corporation | 88.33B | -0.92% | 913,681 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 87.44B | 2.41% | 2,037,839 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 82.29B | -2.00% | 2,397,632 | 76.39B |
| 26 | CI | The Cigna Group | 72.53B | -1.16% | 1,078,031 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 71.32B | -0.68% | 29,188,544 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 61.11B | -2.30% | 1,080,308 | 14.92B |
| 29 | ARGX | argenx SE | 51.88B | 0.01% | 252,113 | 4.74B |
| 30 | COR | Cencora, Inc. | 51.50B | -1.73% | 1,625,801 | 328.68B |
| 31 | EW | Edwards Lifesciences Corporation | 50.76B | 1.95% | 7,649,920 | 6.30B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 47.99B | -4.82% | 4,439,807 | 28.34B |
| 33 | MDLN | Medline Inc. | 46.96B | -2.22% | 13,611,405 | 29.14B |
| 34 | CAH | Cardinal Health, Inc. | 45.71B | -0.84% | 2,032,173 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.71B | 0.58% | 604,389 | 4.45B |
| 36 | TEVA | Teva Pharmaceutical Industries Limited | 40.34B | -1.93% | 6,626,153 | 17.35B |
| 37 | BDX | Becton, Dickinson and Company | 40.04B | -1.22% | 2,387,011 | 22.23B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.47B | -2.10% | 1,186,174 | 4.29B |
| 39 | HUM | Humana Inc. | 39.42B | 7.49% | 1,954,748 | 137.20B |
| 40 | HLN | Haleon plc | 38.93B | -2.43% | 9,428,302 | 14.85B |
| 41 | A | Agilent Technologies, Inc. | 38.41B | 0.33% | 2,678,076 | 7.23B |
| 42 | WAT | Waters Corporation | 37.13B | -1.41% | 1,529,446 | 3.77B |
| 43 | RVMD | Revolution Medicines, Inc. | 34.80B | 3.94% | 6,730,920 | - |
| 44 | ZTS | Zoetis Inc. | 32.52B | -0.17% | 5,046,705 | 9.53B |
| 45 | ALC | Alcon Inc. | 32.06B | -0.89% | 1,926,135 | 10.63B |
| 46 | RPRX | Royalty Pharma plc | 31.77B | -1.04% | 4,352,785 | 2.44B |
| 47 | NTRA | Natera, Inc. | 31.34B | -2.04% | 1,334,257 | 2.50B |
| 48 | IQV | IQVIA Holdings Inc. | 31.18B | 2.53% | 1,404,816 | 16.63B |
| 49 | ONC | BeOne Medicines AG | 31.09B | -2.86% | 373,491 | 5.70B |
| 50 | VEEV | Veeva Systems Inc. | 30.79B | 8.21% | 5,645,949 | 3.20B |
| 51 | CNC | Centene Corporation | 30.62B | 4.03% | 5,742,957 | 178.33B |
| 52 | DXCM | DexCom, Inc. | 28.89B | 1.53% | 6,140,949 | 4.82B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 28.52B | 0.56% | 8,589,615 | 20.98B |
| 54 | BIIB | Biogen Inc. | 28.38B | -1.92% | 841,500 | 9.94B |
| 55 | RMD | ResMed Inc. | 27.04B | -2.17% | 2,439,096 | 5.54B |
| 56 | ILMN | Illumina, Inc. | 24.87B | 0.88% | 2,190,683 | 4.39B |
| 57 | PHG | Koninklijke Philips N.V. | 24.77B | -1.17% | 958,572 | 20.34B |
| 58 | MTD | Mettler-Toledo International Inc. | 23.92B | 0.25% | 209,522 | 4.09B |
| 59 | BNTX | BioNTech SE | 23.19B | -4.43% | 1,296,510 | 3.23B |
| 60 | UTHR | United Therapeutics Corporation | 23.12B | -2.19% | 498,539 | 3.17B |
| 61 | INSM | Insmed Incorporated | 22.98B | -0.82% | 3,357,738 | 819.56M |
| 62 | WST | West Pharmaceutical Services, Inc. | 22.35B | -2.02% | 702,453 | 3.22B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.28B | -1.39% | 609,501 | 11.28B |
| 64 | LH | Labcorp Holdings Inc. | 21.06B | -1.23% | 533,234 | 14.14B |
| 65 | ROIV | Roivant Sciences Ltd. | 20.92B | -3.00% | 4,115,187 | 8.26M |
| 66 | STE | STERIS plc | 20.60B | -0.78% | 702,382 | 5.94B |
| 67 | INCY | Incyte Corporation | 19.10B | -1.19% | 1,592,435 | 5.36B |
| 68 | VTRS | Viatris Inc. | 18.41B | -2.77% | 12,469,832 | 14.56B |
| 69 | MRNA | Moderna, Inc. | 18.28B | -2.39% | 6,177,796 | 2.23B |
| 70 | GH | Guardant Health, Inc. | 17.12B | -0.42% | 2,414,050 | 1.08B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 16.19B | 1.71% | 1,220,836 | 3.10B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.05B | 0.74% | 2,704,141 | 8.41B |
| 73 | GMAB | Genmab A/S | 15.65B | -3.34% | 1,711,254 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 14.65B | -2.98% | 1,753,169 | 21.46B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.60B | -1.63% | 945,744 | 4.44B |
| 76 | ASND | Ascendis Pharma A/S | 13.59B | -2.36% | 663,394 | 998.25M |
| 77 | SOLV | Solventum Corporation | 13.13B | 1.19% | 2,350,913 | 8.26B |
| 78 | MEDP | Medpace Holdings, Inc. | 12.89B | 0.98% | 251,195 | 2.68B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 12.80B | -1.36% | 8,117,609 | 579.96M |
| 80 | EXEL | Exelixis, Inc. | 12.64B | -0.40% | 2,447,430 | 2.38B |
| 81 | SNN | Smith & Nephew plc | 12.57B | -0.71% | 595,221 | 6.16B |
| 82 | PEN | Penumbra, Inc. | 12.54B | 0.20% | 362,751 | 1.45B |
| 83 | IONS | Ionis Pharmaceuticals, Inc. | 12.46B | -1.46% | 1,467,683 | 1.06B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 12.34B | -2.76% | 2,445,957 | 13.65B |
| 85 | SMMT | Summit Therapeutics Inc. | 12.19B | -10.43% | 19,587,360 | - |
| 86 | DVA | DaVita Inc. | 12.19B | -2.34% | 966,227 | 13.84B |
| 87 | ALGN | Align Technology, Inc. | 12.16B | -2.96% | 856,901 | 4.10B |
| 88 | RGC | Regencell Bioscience Holdings Limited | 11.98B | 1.13% | 73,369 | - |
| 89 | AXSM | Axsome Therapeutics, Inc. | 11.85B | -1.80% | 499,180 | 708.24M |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.82B | -0.75% | 5,324,869 | 4.89B |
| 91 | COO | The Cooper Companies, Inc. | 11.74B | -1.67% | 4,245,168 | 4.15B |
| 92 | FMS | Fresenius Medical Care AG | 11.36B | -2.46% | 785,210 | 22.32B |
| 93 | RVTY | Revvity, Inc. | 11.21B | -3.85% | 2,165,812 | 2.90B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.14B | -2.71% | 1,744,079 | 3.58B |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.10B | -3.23% | 234,031 | 1.13B |
| 96 | GMED | Globus Medical, Inc. | 10.83B | -2.56% | 1,921,560 | 3.10B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.64B | -3.94% | 2,818,160 | 3.24B |
| 98 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.59B | -3.48% | 2,287,832 | 622.01M |
| 99 | ICLR | ICON Public Limited Company | 10.57B | 1.44% | 1,308,108 | 8.25B |
| 100 | ABVX | ABIVAX Société Anonyme | 10.35B | -2.22% | 8,092,795 | 5.67M |
| 101 | PODD | Insulet Corporation | 10.26B | 2.20% | 1,316,357 | 2.90B |
| 102 | EHC | Encompass Health Corporation | 10.19B | -2.95% | 873,737 | 6.07B |
| 103 | CYTK | Cytokinetics, Incorporated | 10.00B | -4.01% | 1,659,898 | 105.82M |
| 104 | ENSG | The Ensign Group, Inc. | 9.56B | -1.58% | 574,436 | 5.27B |
| 105 | MOH | Molina Healthcare, Inc. | 9.55B | 5.56% | 910,118 | 43.10B |
| 106 | BAX | Baxter International Inc. | 9.50B | -2.02% | 8,560,419 | 11.32B |
| 107 | TEM | Tempus AI, Inc. | 9.48B | 4.62% | 9,746,219 | 1.36B |
| 108 | MASI | Masimo Corporation | 9.35B | 0.08% | 668,471 | 1.56B |
| 109 | PRAX | Praxis Precision Medicines, Inc. | 9.34B | -4.23% | 290,920 | 7.46M |
| 110 | BRKR | Bruker Corporation | 8.90B | -0.76% | 4,137,002 | 3.46B |
| 111 | KRYS | Krystal Biotech, Inc. | 8.79B | -3.54% | 263,134 | 417.30M |
| 112 | CRL | Charles River Laboratories International, Inc. | 8.77B | 0.75% | 996,244 | 4.03B |
| 113 | UHS | Universal Health Services, Inc. | 8.76B | -0.97% | 1,439,924 | 17.76B |
| 114 | HSIC | Henry Schein, Inc. | 8.70B | -0.24% | 1,356,089 | 13.38B |
| 115 | BIO | Bio-Rad Laboratories, Inc. | 8.17B | -2.25% | 442,211 | 2.59B |
| 116 | HALO | Halozyme Therapeutics, Inc. | 8.08B | 2.40% | 2,387,417 | 1.51B |
| 117 | TECH | Bio-Techne Corporation | 7.95B | -1.72% | 2,207,648 | 1.21B |
| 118 | IBRX | ImmunityBio, Inc. | 7.58B | -3.72% | 20,423,935 | 140.98M |
| 119 | HQY | HealthEquity, Inc. | 7.58B | 3.01% | 1,399,172 | 1.34B |
| 120 | CORT | Corcept Therapeutics Incorporated | 7.56B | 1.37% | 1,097,203 | 769.10M |
| 121 | QGEN | Qiagen N.V. | 7.48B | -1.12% | 1,958,254 | 2.10B |
| 122 | NUVL | Nuvalent, Inc. | 7.35B | -15.74% | 2,945,029 | - |
| 123 | ATR | AptarGroup, Inc. | 7.17B | -3.00% | 706,852 | 3.87B |
| 124 | PCVX | Vaxcyte, Inc. | 7.06B | -4.84% | 1,360,111 | - |
| 125 | ALKS | Alkermes plc | 7.05B | 0.19% | 2,406,094 | 1.56B |
| 126 | RGEN | Repligen Corporation | 6.94B | -0.69% | 695,090 | 763.34M |
| 127 | OSCR | Oscar Health, Inc. | 6.92B | 3.33% | 7,585,592 | 13.30B |
| 128 | IMVT | Immunovant, Inc. | 6.75B | -1.32% | 1,593,137 | - |
| 129 | GRFS | Grifols, S.A. | 6.56B | -1.40% | 1,010,723 | 8.58B |
| 130 | KYMR | Kymera Therapeutics, Inc. | 6.45B | -3.62% | 437,530 | 51.48M |
| 131 | HIMS | Hims & Hers Health, Inc. | 6.43B | 6.16% | 21,146,336 | 2.37B |
| 132 | LNTH | Lantheus Holdings, Inc. | 6.32B | -2.19% | 839,781 | 1.55B |
| 133 | AVTR | Avantor, Inc. | 6.27B | 0.77% | 13,033,132 | 6.55B |
| 134 | CNTA | Centessa Pharmaceuticals plc | 6.17B | 0.25% | 1,458,552 | 15.00M |
| 135 | SYRE | Spyre Therapeutics, Inc. | 6.13B | -4.03% | 921,839 | - |
| 136 | PTCT | PTC Therapeutics, Inc. | 6.12B | -0.07% | 1,135,216 | 827.11M |
| 137 | PTGX | Protagonist Therapeutics, Inc. | 6.10B | -4.66% | 817,045 | 74.06M |
| 138 | GKOS | Glaukos Corporation | 6.05B | -0.22% | 1,431,293 | 551.35M |
| 139 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.02B | -0.51% | 468,227 | 217.17M |
| 140 | CELC | Celcuity Inc. | 6.00B | -7.47% | 1,929,220 | - |
| 141 | COGT | Cogent Biosciences, Inc. | 5.95B | -0.43% | 3,073,931 | - |
| 142 | APGE | Apogee Therapeutics, Inc. | 5.94B | -3.46% | 806,702 | - |
| 143 | MIRM | Mirum Pharmaceuticals, Inc. | 5.87B | -5.09% | 599,068 | 569.61M |
| 144 | BLTE | Belite Bio, Inc | 5.78B | 1.96% | 398,827 | - |
| 145 | SRRK | Scholar Rock Holding Corporation | 5.68B | -3.87% | 1,128,882 | - |
| 146 | TFX | Teleflex Incorporated | 5.65B | -0.83% | 854,934 | 2.13B |
| 147 | PACS | PACS Group, Inc. | 5.63B | -3.03% | 832,535 | 5.43B |
| 148 | CHE | Chemed Corporation | 5.59B | -0.84% | 180,746 | 2.54B |
| 149 | BLCO | Bausch + Lomb Corporation | 5.49B | -1.66% | 774,052 | 5.21B |
| 150 | TGTX | TG Therapeutics, Inc. | 5.30B | -1.40% | 1,639,500 | 700.35M |
| 151 | CRSP | CRISPR Therapeutics AG | 5.23B | -3.54% | 1,426,137 | 4.10M |
| 152 | CGON | CG Oncology, Inc. | 5.22B | -4.91% | 814,460 | 5.07M |
| 153 | LQDA | Liquidia Corporation | 5.22B | -5.04% | 1,339,092 | 288.07M |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 5.16B | -2.41% | 1,347,994 | 7.50M |
| 155 | STVN | Stevanato Group S.p.A. | 5.15B | 1.13% | 225,145 | 1.39B |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 4.89B | -3.83% | 604,264 | 1.34M |
| 157 | LEGN | Legend Biotech Corporation | 4.74B | -6.08% | 3,118,905 | 1.14B |
| 158 | HNGE | Hinge Health, Inc. | 4.71B | 8.38% | 3,356,897 | 646.34M |
| 159 | CAI | Caris Life Sciences, Inc. | 4.65B | -1.61% | 2,611,335 | 907.29M |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 4.61B | -0.94% | 203,667 | 274.48M |
| 161 | SHC | Sotera Health Company | 4.43B | -0.64% | 1,891,502 | 1.19B |
| 162 | EWTX | Edgewise Therapeutics, Inc. | 4.33B | 17.86% | 4,468,564 | - |
| 163 | ERAS | Erasca, Inc. | 4.30B | 7.63% | 10,520,765 | - |
| 164 | MANE | Veradermics, Incorporated | 4.24B | 0.59% | 510,387 | - |
| 165 | TWST | Twist Bioscience Corporation | 4.23B | 1.48% | 1,295,198 | 409.48M |
| 166 | WAY | Waystar Holding Corp. | 4.20B | 10.10% | 3,329,491 | 1.16B |
| 167 | BLLN | BillionToOne, Inc. | 4.19B | -7.95% | 814,862 | 354.54M |
| 168 | TVTX | Travere Therapeutics, Inc. | 4.19B | -4.54% | 1,382,182 | 536.20M |
| 169 | RDNT | RadNet, Inc. | 4.16B | -4.75% | 920,755 | 2.14B |
| 170 | DOCS | Doximity, Inc. | 4.12B | 5.37% | 4,035,930 | 644.86M |
| 171 | AMRX | Amneal Pharmaceuticals, Inc. | 4.12B | -2.05% | 1,401,314 | 3.05B |
| 172 | LIVN | LivaNova PLC | 4.05B | 0.01% | 763,632 | 1.43B |
| 173 | VCYT | Veracyte, Inc. | 3.84B | 3.97% | 1,527,107 | 541.74M |
| 174 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.13% | 1,591,057 | 596.96M |
| 175 | NVST | Envista Holdings Corporation | 3.80B | -0.76% | 3,332,700 | 2.81B |
| 176 | TXG | 10x Genomics, Inc. | 3.76B | 4.52% | 3,026,397 | 638.78M |
| 177 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.73B | 0.10% | 750,406 | 754.05M |
| 178 | NAMS | NewAmsterdam Pharma Company N.V. | 3.72B | -5.61% | 1,854,823 | 22.57M |
| 179 | MMSI | Merit Medical Systems, Inc. | 3.70B | -1.60% | 715,205 | 1.54B |
| 180 | ACAD | ACADIA Pharmaceuticals Inc. | 3.68B | -0.65% | 1,119,175 | 1.10B |
| 181 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.64B | -2.90% | 799,145 | 18.07M |
| 182 | VKTX | Viking Therapeutics, Inc. | 3.63B | -4.49% | 1,490,130 | - |
| 183 | IRTC | iRhythm Holdings, Inc. | 3.59B | -4.15% | 430,939 | 787.85M |
| 184 | OGN | Organon & Co. | 3.51B | 0.15% | 3,527,453 | 6.16B |
| 185 | MMED | MiniMed Group, Inc. | 3.37B | -0.33% | 1,086,619 | 2.99B |
| 186 | TNGX | Tango Therapeutics, Inc. | 3.34B | 5.10% | 3,146,318 | 56.99M |
| 187 | ORKA | Oruka Therapeutics, Inc. | 3.32B | -6.01% | 1,126,386 | - |
| 188 | ICUI | ICU Medical, Inc. | 3.29B | -2.77% | 307,277 | 2.16B |
| 189 | DNLI | Denali Therapeutics Inc. | 3.24B | -2.99% | 1,678,909 | - |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.23B | 1.53% | 986,027 | 2.23B |
| 191 | RCUS | Arcus Biosciences, Inc. | 3.23B | 1.30% | 1,450,131 | 236.00M |
| 192 | OPCH | Option Care Health, Inc. | 3.21B | -1.96% | 2,328,670 | 5.67B |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.16B | -0.11% | 136,905 | 803.79M |
| 194 | RLAY | Relay Therapeutics, Inc. | 3.11B | 1.49% | 2,260,698 | 10.68M |
| 195 | BEAM | Beam Therapeutics Inc. | 3.10B | -5.44% | 1,648,043 | 164.01M |
| 196 | DYN | Dyne Therapeutics, Inc. | 3.08B | -3.62% | 1,442,215 | - |
| 197 | LFST | LifeStance Health Group, Inc. | 3.08B | 2.98% | 2,221,721 | 1.49B |
| 198 | ITGR | Integer Holdings Corporation | 3.06B | 0.87% | 611,933 | 1.86B |
| 199 | HAE | Haemonetics Corporation | 3.05B | -0.87% | 735,873 | 1.33B |
| 200 | KLRA | Kailera Therapeutics, Inc. | 3.00B | 1.05% | 299,250 | - |
| 201 | WRBY | Warby Parker Inc. | 2.99B | -0.57% | 2,428,383 | 890.57M |
| 202 | BKD | Brookdale Senior Living Inc. | 2.91B | -5.28% | 6,133,535 | 3.00B |
| 203 | NHC | National HealthCare Corporation | 2.80B | -2.72% | 145,212 | 1.53B |
| 204 | GRAL | GRAIL, Inc. | 2.76B | -10.16% | 2,612,565 | 156.12M |
| 205 | ALHC | Alignment Healthcare, Inc. | 2.75B | -13.19% | 12,723,911 | 4.26B |
| 206 | IRON | Disc Medicine, Inc. | 2.75B | 3.45% | 636,528 | - |
| 207 | GPCR | Structure Therapeutics Inc. | 2.74B | -2.01% | 670,468 | - |
| 208 | ARQT | Arcutis Biotherapeutics, Inc. | 2.69B | 0.05% | 1,602,388 | 415.62M |
| 209 | PRVA | Privia Health Group, Inc. | 2.69B | -0.93% | 802,599 | 2.25B |
| 210 | HTFL | HeartFlow, Inc. | 2.67B | 0.06% | 1,246,172 | 191.42M |
| 211 | DFTX | Definium Therapeutics, Inc. | 2.62B | -0.54% | 1,736,077 | - |
| 212 | SUPN | Supernus Pharmaceuticals, Inc. | 2.60B | -3.07% | 571,041 | 776.83M |
| 213 | ALMS | Alumis Inc. | 2.59B | -5.88% | 1,643,622 | 8.40M |
| 214 | GMRS | GMR Solutions Inc. | 2.58B | -7.52% | 627,017 | 5.74B |
| 215 | MLYS | Mineralys Therapeutics, Inc. | 2.57B | -1.24% | 1,353,229 | - |
| 216 | IDYA | IDEAYA Biosciences, Inc. | 2.54B | -1.80% | 873,016 | 225.27M |
| 217 | TARS | Tarsus Pharmaceuticals, Inc. | 2.54B | -0.79% | 440,028 | 535.08M |
| 218 | GRDN | Guardian Pharmacy Services, Inc. | 2.49B | 1.34% | 407,280 | 1.46B |
| 219 | ADPT | Adaptive Biotechnologies Corporation | 2.44B | 0.53% | 1,571,655 | 295.41M |
| 220 | VERA | Vera Therapeutics, Inc. | 2.44B | -4.45% | 921,865 | - |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.37B | -4.10% | 1,020,660 | 865.00K |
| 222 | IMNM | Immunome, Inc. | 2.35B | -4.81% | 1,524,375 | 4.02M |
| 223 | TMDX | TransMedics Group, Inc. | 2.33B | 0.49% | 1,332,393 | 635.89M |
| 224 | KOD | Kodiak Sciences Inc. | 2.30B | 0.54% | 670,709 | - |
| 225 | ELVN | Enliven Therapeutics, Inc. | 2.28B | -5.21% | 694,833 | - |
| 226 | RARE | Ultragenyx Pharmaceutical Inc. | 2.24B | -4.55% | 2,327,957 | 670.00M |
| 227 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.18B | -3.82% | 3,084,266 | 885.72M |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.18B | -3.32% | 820,832 | 1.09B |
| 229 | NKTR | Nektar Therapeutics | 2.16B | -1.57% | 871,047 | 55.63M |
| 230 | ACHC | Acadia Healthcare Company, Inc. | 2.14B | 0.47% | 2,066,103 | 3.37B |
| 231 | LMAT | LeMaitre Vascular, Inc. | 2.09B | -3.41% | 246,417 | 256.28M |
| 232 | HCM | HUTCHMED (China) Limited | 2.08B | -0.44% | 143,285 | 548.51M |
| 233 | CLOV | Clover Health Investments, Corp. | 2.06B | -1.51% | 5,756,433 | 2.21B |
| 234 | AXGN | Axogen, Inc. | 2.06B | -1.93% | 885,585 | 238.11M |
| 235 | PGNY | Progyny, Inc. | 2.05B | 2.50% | 1,823,347 | 1.29B |
| 236 | SEM | Select Medical Holdings Corporation | 2.05B | 0.06% | 1,759,231 | 5.52B |
| 237 | PHVS | Pharvaris N.V. | 2.03B | -3.51% | 143,389 | - |
| 238 | RXRX | Recursion Pharmaceuticals, Inc. | 2.01B | 5.57% | 30,989,115 | 66.41M |
| 239 | XRAY | DENTSPLY SIRONA Inc. | 2.01B | -4.30% | 4,515,371 | 3.68B |
| 240 | ESTA | Establishment Labs Holdings Inc. | 2.00B | -3.69% | 622,683 | 229.58M |
| 241 | BHC | Bausch Health Companies Inc. | 1.98B | -0.93% | 1,536,023 | 10.53B |
| 242 | TRVI | Trevi Therapeutics, Inc. | 1.98B | -1.34% | 1,125,066 | - |
| 243 | ABCL | AbCellera Biologics Inc. | 1.97B | 4.70% | 9,678,368 | 79.21M |
| 244 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -0.13% | 1,203,240 | 298.30M |
| 245 | OMCL | Omnicell, Inc. | 1.96B | -2.22% | 640,125 | 1.23B |
| 246 | OCUL | Ocular Therapeutix, Inc. | 1.96B | -0.89% | 2,064,853 | 52.04M |
| 247 | NBTX | Nanobiotix S.A. | 1.94B | -5.94% | 54,543 | 38.27M |
| 248 | NEOG | Neogen Corporation | 1.94B | -0.56% | 2,807,063 | 870.56M |
| 249 | ZLAB | Zai Lab Limited | 1.92B | -3.39% | 914,965 | 453.28M |
| 250 | NTLA | Intellia Therapeutics, Inc. | 1.92B | -2.42% | 3,569,484 | 66.09M |
| 251 | NVCR | NovoCure Limited | 1.92B | -2.82% | 1,603,691 | 674.41M |
| 252 | CMPS | COMPASS Pathways plc | 1.91B | 8.65% | 8,952,989 | - |
| 253 | MESO | Mesoblast Limited | 1.90B | -3.51% | 153,772 | 65.38M |
| 254 | STOK | Stoke Therapeutics, Inc. | 1.90B | -1.42% | 467,649 | 32.08M |
| 255 | VRDN | Viridian Therapeutics, Inc. | 1.87B | -3.75% | 1,369,523 | 70.92M |
| 256 | ASTH | Astrana Health, Inc. | 1.87B | 0.37% | 413,828 | 3.53B |
| 257 | SRPT | Sarepta Therapeutics, Inc. | 1.86B | -1.45% | 3,098,307 | 2.18B |
| 258 | SION | Sionna Therapeutics, Inc. | 1.85B | -4.48% | 400,139 | - |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 1.84B | 0.70% | 752,316 | 899.11M |
| 260 | ADMA | ADMA Biologics, Inc. | 1.83B | -1.00% | 3,548,862 | 509.86M |
| 261 | LKFT | Lakefront Biotherapeutics NV | 1.82B | -2.86% | 214,498 | 1.20B |
| 262 | TYRA | Tyra Biosciences, Inc. | 1.81B | -9.04% | 1,077,351 | - |
| 263 | NRIX | Nurix Therapeutics, Inc. | 1.80B | -2.08% | 851,622 | 71.78M |
| 264 | ZYME | Zymeworks Inc. | 1.79B | -2.35% | 1,910,937 | 81.26M |
| 265 | QURE | uniQure N.V. | 1.78B | -1.09% | 1,305,925 | 18.09M |
| 266 | RAPP | Rapport Therapeutics, Inc. | 1.77B | -6.05% | 256,488 | 20.00M |
| 267 | ATAI | AtaiBeckley Inc. | 1.77B | 6.40% | 7,033,166 | 3.49M |
| 268 | IOVA | Iovance Biotherapeutics, Inc. | 1.77B | -3.41% | 14,458,961 | 285.61M |
| 269 | AAPG | Ascentage Pharma Group International | 1.76B | -4.65% | 8,267 | 82.08M |
| 270 | MD | Pediatrix Medical Group, Inc. | 1.73B | 0.37% | 997,844 | 1.93B |
| 271 | NVAX | Novavax, Inc. | 1.73B | -4.19% | 4,682,723 | 596.34M |
| 272 | NUVB | Nuvation Bio Inc. | 1.73B | 3.77% | 5,960,577 | 143.05M |
| 273 | BHVN | Biohaven Ltd. | 1.72B | 3.81% | 2,701,942 | - |
| 274 | TSHA | Taysha Gene Therapies, Inc. | 1.72B | 1.70% | 1,561,176 | 7.47M |
| 275 | SGRY | Surgery Partners, Inc. | 1.71B | -1.05% | 2,129,384 | 3.34B |
| 276 | PLSE | Pulse Biosciences, Inc. | 1.71B | -1.32% | 202,794 | 751.00K |
| 277 | GHRS | GH Research PLC | 1.70B | 3.50% | 286,320 | - |
| 278 | UFPT | UFP Technologies, Inc. | 1.69B | -0.90% | 214,253 | 608.85M |
| 279 | SLS | SELLAS Life Sciences Group, Inc. | 1.69B | -2.58% | 7,363,201 | - |
| 280 | VCEL | Vericel Corporation | 1.68B | -1.53% | 530,058 | 292.09M |
| 281 | SNDX | Syndax Pharmaceuticals, Inc. | 1.67B | -3.78% | 1,492,842 | 217.17M |
| 282 | AGIO | Agios Pharmaceuticals, Inc. | 1.67B | -4.76% | 853,881 | 66.05M |
| 283 | GENB | Generate Biomedicines, Inc. | 1.66B | -1.14% | 678,979 | 30.30M |
| 284 | GLUE | Monte Rosa Therapeutics, Inc. | 1.66B | -0.20% | 1,005,559 | 42.95M |
| 285 | CAPR | Capricor Therapeutics, Inc. | 1.65B | -4.77% | 726,677 | 11.13M |
| 286 | ADUS | Addus HomeCare Corporation | 1.64B | -2.43% | 217,890 | 1.45B |
| 287 | ANIP | ANI Pharmaceuticals, Inc. | 1.63B | -2.29% | 427,929 | 923.71M |
| 288 | PVLA | Palvella Therapeutics, Inc. | 1.61B | -4.96% | 242,282 | - |
| 289 | INVA | Innoviva, Inc. | 1.59B | 0.42% | 1,860,185 | 420.69M |
| 290 | PRCT | PROCEPT BioRobotics Corporation | 1.59B | 5.81% | 1,453,358 | 322.02M |
| 291 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.56B | -1.95% | 687,308 | -665.00K |
| 292 | ANAB | AnaptysBio, Inc. | 1.55B | -4.54% | 725,056 | 232.39M |
| 293 | AGL | agilon health, inc. | 1.54B | 0.28% | 190,058 | 5.82B |
| 294 | WGS | GeneDx Holdings Corp. | 1.54B | 0.02% | 1,156,150 | 442.68M |
| 295 | DMRA | Damora Therapeutics, Inc. | 1.53B | -0.12% | 307,386 | - |
| 296 | SNDA | Sonida Senior Living, Inc. | 1.53B | -7.36% | 887,363 | 367.34M |
| 297 | VIR | Vir Biotechnology, Inc. | 1.52B | -5.35% | 1,749,218 | 65.50M |
| 298 | IMTX | Immatics N.V. | 1.49B | -3.21% | 636,537 | 43.00M |
| 299 | FTRE | Fortrea Holdings Inc. | 1.49B | 2.40% | 1,714,403 | 2.71B |
| 300 | PRGO | Perrigo Company plc | 1.49B | -2.62% | 2,643,377 | 4.18B |
| 301 | IMCR | Immunocore Holdings plc | 1.48B | 0.83% | 873,912 | 412.81M |
| 302 | STAA | STAAR Surgical Company | 1.47B | -1.14% | 950,161 | 290.38M |
| 303 | PGEN | Precigen, Inc. | 1.47B | -5.07% | 4,835,655 | 31.60M |
| 304 | MBX | MBX Biosciences, Inc. | 1.46B | -2.61% | 347,800 | - |
| 305 | INBX | Inhibrx Biosciences, Inc. | 1.46B | -4.54% | 261,434 | 1.30M |
| 306 | AVAH | Aveanna Healthcare Holdings Inc. | 1.45B | -6.97% | 1,835,115 | 2.52B |
| 307 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.26% | 2,605,772 | 114.48M |
| 308 | AVBP | ArriVent BioPharma, Inc. | 1.43B | 1.35% | 1,253,727 | - |
| 309 | TDOC | Teladoc Health, Inc. | 1.43B | 3.94% | 4,827,429 | 2.51B |
| 310 | ALMR | Alamar Biosciences, Inc. | 1.42B | 0.34% | 136,319 | 87.16M |
| 311 | ARDX | Ardelyx, Inc. | 1.42B | -5.13% | 2,628,558 | 427.68M |
| 312 | MAZE | Maze Therapeutics, Inc. | 1.41B | -3.78% | 522,481 | 20.00M |
| 313 | MLTX | MoonLake Immunotherapeutics | 1.39B | -1.88% | 679,872 | - |
| 314 | HCSG | Healthcare Services Group, Inc. | 1.37B | -3.20% | 735,062 | 1.85B |
| 315 | NEO | NeoGenomics, Inc. | 1.36B | -0.76% | 1,205,657 | 745.97M |
| 316 | BCAX | Bicara Therapeutics Inc. | 1.35B | -5.20% | 740,345 | - |
| 317 | SEPN | Septerna, Inc. | 1.35B | -0.73% | 359,290 | 72.26M |
| 318 | MPLT | MapLight Therapeutics, Inc. | 1.35B | 1.54% | 270,553 | - |
| 319 | ATRC | AtriCure, Inc. | 1.34B | -4.30% | 811,118 | 552.16M |
| 320 | NNNN | Anbio Biotechnology | 1.32B | -12.32% | 27,649 | 8.65M |
| 321 | AHCO | AdaptHealth Corp. | 1.32B | -1.97% | 1,944,703 | 3.29B |
| 322 | ARDT | Ardent Health, Inc. | 1.32B | -0.11% | 289,712 | 6.43B |
| 323 | URGN | UroGen Pharma Ltd. | 1.32B | -3.91% | 1,067,967 | 140.49M |
| 324 | TNDM | Tandem Diabetes Care, Inc. | 1.31B | 11.16% | 5,618,581 | 1.03B |
| 325 | SVRA | Savara Inc. | 1.31B | -0.96% | 2,071,807 | - |
| 326 | BLFS | BioLife Solutions, Inc. | 1.30B | 6.86% | 1,258,810 | 101.66M |
| 327 | AHG | Akso Health Group | 1.28B | -1.97% | 2,322 | 14.84M |
| 328 | HROW | Harrow, Inc. | 1.27B | -3.12% | 525,187 | 268.68M |
| 329 | ENOV | Enovis Corporation | 1.25B | -4.32% | 1,340,896 | 2.28B |
| 330 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.23B | -1.04% | 2,052,496 | 204.73M |
| 331 | IART | Integra LifeSciences Holdings Corporation | 1.22B | -2.31% | 800,427 | 1.64B |
| 332 | PAHC | Phibro Animal Health Corporation | 1.21B | -2.99% | 478,258 | 1.50B |
| 333 | WVE | Wave Life Sciences Ltd. | 1.20B | -4.86% | 3,755,329 | 71.80M |
| 334 | BFLY | Butterfly Network, Inc. | 1.20B | 1.10% | 4,063,239 | 102.92M |
| 335 | COAG | Hemab Therapeutics Holdings, Inc. | 1.20B | -4.81% | 128,895 | - |
| 336 | SDGR | Schrödinger, Inc. | 1.18B | 3.95% | 2,280,787 | 254.91M |
| 337 | PSNL | Personalis, Inc. | 1.18B | -1.23% | 3,001,305 | 64.52M |
| 338 | KMTS | Kestra Medical Technologies, Ltd. | 1.18B | -5.03% | 209,838 | 83.72M |
| 339 | CDNA | CareDx, Inc. | 1.18B | -0.09% | 598,942 | 412.82M |
| 340 | INSP | Inspire Medical Systems, Inc. | 1.18B | -1.26% | 1,635,721 | 915.25M |
| 341 | IRMD | IRADIMED CORPORATION | 1.18B | 1.53% | 126,584 | 86.28M |
| 342 | AVNS | Avanos Medical, Inc. | 1.17B | 1.01% | 3,534,242 | 715.90M |
| 343 | ATEC | Alphatec Holdings, Inc. | 1.15B | -3.48% | 2,862,228 | 787.08M |
| 344 | ZBIO | Zenas BioPharma, Inc. | 1.15B | -1.25% | 636,861 | 10.00M |
| 345 | AMN | AMN Healthcare Services, Inc. | 1.14B | 1.28% | 793,975 | 3.42B |
| 346 | AVLN | Avalyn Pharma Inc. | 1.11B | -7.37% | 155,785 | - |
| 347 | DBVT | DBV Technologies S.A. | 1.11B | -1.57% | 180,928 | 5.74M |
| 348 | PNTG | The Pennant Group, Inc. | 1.11B | -6.57% | 465,187 | 1.02B |
| 349 | OLMA | Olema Pharmaceuticals, Inc. | 1.11B | -3.64% | 1,346,478 | - |
| 350 | EYPT | EyePoint, Inc. | 1.10B | -3.17% | 1,308,111 | 7.61M |
| 351 | EVO | Evotec SE | 1.10B | - | 17,619 | 859.03M |
| 352 | OMDA | Omada Health, Inc. | 1.09B | 2.28% | 1,153,348 | 283.30M |
| 353 | MNKD | MannKind Corporation | 1.09B | -6.37% | 8,345,289 | 360.78M |
| 354 | AKTS | Aktis Oncology, Inc. | 1.08B | -6.08% | 98,702 | 8.28M |
| 355 | AZTA | Azenta, Inc. | 1.07B | 1.35% | 1,146,805 | 596.48M |
| 356 | CRON | Cronos Group Inc. | 1.06B | -0.70% | 971,701 | 159.54M |
| 357 | OPK | OPKO Health, Inc. | 1.06B | -4.11% | 3,337,256 | 581.12M |
| 358 | XERS | Xeris Biopharma Holdings, Inc. | 1.05B | -1.46% | 1,653,356 | 314.85M |
| 359 | CNMD | CONMED Corporation | 1.04B | -2.94% | 525,132 | 1.37B |
| 360 | GDRX | GoodRx Holdings, Inc. | 1.04B | 5.48% | 2,465,592 | 787.89M |
| 361 | COLL | Collegium Pharmaceutical, Inc. | 1.03B | -5.44% | 512,041 | 796.33M |
| 362 | AORT | Artivion, Inc. | 1.02B | -5.14% | 807,690 | 458.69M |
| 363 | ABSI | Absci Corporation | 1.02B | -3.41% | 4,987,381 | 1.84M |
| 364 | CRVS | Corvus Pharmaceuticals, Inc. | 1.02B | -2.66% | 1,580,690 | - |
| 365 | IVA | Inventiva S.A. | 1.01B | -3.25% | 358,214 | 7.94M |
| 366 | ALVO | Alvotech | 1.01B | -4.17% | 754,147 | 562.04M |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 996.23M | -1.40% | 988,546 | - |
| 368 | INNV | InnovAge Holding Corp. | 990.88M | -3.82% | 367,958 | 949.17M |
| 369 | CERT | Certara, Inc. | 952.06M | 5.15% | 3,232,024 | 419.75M |
| 370 | USPH | U.S. Physical Therapy, Inc. | 951.63M | -2.69% | 266,835 | 787.69M |
| 371 | SPRY | ARS Pharmaceuticals, Inc. | 936.43M | 3.97% | 1,973,350 | 98.99M |
| 372 | ORIC | ORIC Pharmaceuticals, Inc. | 929.59M | 6.27% | 3,679,864 | - |
| 373 | PHAR | Pharming Group N.V. | 921.89M | 0.85% | 11,156 | 369.49M |
| 374 | LXRX | Lexicon Pharmaceuticals, Inc. | 919.49M | -5.05% | 1,830,118 | 69.64M |
| 375 | JBIO | Jade Biosciences, Inc. | 917.60M | -11.64% | 2,689,144 | - |
| 376 | ANNX | Annexon, Inc. | 914.24M | 2.95% | 4,731,711 | - |
| 377 | SPTX | Seaport Therapeutics, Inc. | 908.37M | -5.83% | 123,692 | - |
| 378 | MGTX | MeiraGTx Holdings plc | 907.57M | -7.98% | 757,814 | 79.76M |
| 379 | QDEL | QuidelOrtho Corporation | 904.89M | 1.92% | 1,589,585 | 2.66B |
| 380 | PCRX | Pacira BioSciences, Inc. | 903.43M | -1.12% | 482,786 | 734.86M |
| 381 | SANA | Sana Biotechnology, Inc. | 893.32M | -2.73% | 3,401,917 | - |
| 382 | ABUS | Arbutus Biopharma Corporation | 884.97M | -1.75% | 841,418 | 191.45M |
| 383 | NUTX | Nutex Health Inc. | 880.95M | -0.84% | 142,289 | 879.95M |
| 384 | JANX | Janux Therapeutics, Inc. | 878.78M | -1.23% | 725,752 | 13.73M |
| 385 | OCS | Oculis Holding AG | 876.23M | -36.11% | 6,679,659 | 1.40M |
| 386 | TALK | Talkspace, Inc. | 876.09M | 0.58% | 1,545,899 | 238.37M |
| 387 | XNCR | Xencor, Inc. | 874.87M | -0.67% | 709,376 | 97.36M |
| 388 | DRTS | Alpha Tau Medical Ltd. | 871.55M | -10.76% | 1,968,308 | - |
| 389 | AVR | Anteris Technologies Global Corp. | 869.87M | 5.57% | 2,097,702 | 1.85M |
| 390 | INMD | InMode Ltd. | 861.05M | -2.44% | 791,870 | 374.64M |
| 391 | AVTX | Avalo Therapeutics, Inc. | 827.91M | -1.25% | 824,043 | 59.00K |
| 392 | TBPH | Theravance Biopharma, Inc. | 821.75M | -0.75% | 392,249 | 109.78M |
| 393 | AMPH | Amphastar Pharmaceuticals, Inc. | 812.19M | -2.28% | 569,686 | 720.53M |
| 394 | DRUG | Bright Minds Biosciences Inc. | 808.77M | -8.00% | 327,474 | - |
| 395 | ESPR | Esperion Therapeutics, Inc. | 805.76M | - | 18,703,854 | 418.24M |
| 396 | LBRX | LB Pharmaceuticals Inc | 803.81M | 0.21% | 126,887 | - |
| 397 | KURA | Kura Oncology, Inc. | 802.08M | -11.42% | 2,101,931 | 71.64M |
| 398 | ODTX | Odyssey Therapeutics, Inc. | 800.07M | -0.29% | 127,396 | 2.98M |
| 399 | EVMN | Evommune, Inc. | 798.53M | -4.56% | 451,782 | 10.00M |
| 400 | AURA | Aura Biosciences, Inc. | 793.05M | -3.75% | 342,982 | - |
| 401 | VOR | Vor Biopharma Inc. | 789.49M | -2.67% | 536,375 | - |
| 402 | SSII | SS Innovations International, Inc. | 787.76M | - | 49,675 | 48.47M |
| 403 | ETON | Eton Pharmaceuticals, Inc. | 785.61M | -5.81% | 393,433 | 86.93M |
| 404 | GERN | Geron Corporation | 776.24M | -3.20% | 8,361,141 | 196.12M |
| 405 | OMER | Omeros Corporation | 775.86M | -2.90% | 1,262,126 | 9.89M |
| 406 | BIOA | BioAge Labs, Inc. | 764.59M | -0.52% | 319,136 | 10.32M |
| 407 | CTMX | CytomX Therapeutics, Inc. | 751.08M | -4.17% | 6,708,377 | 35.54M |
| 408 | HSTM | HealthStream, Inc. | 747.62M | 2.48% | 302,460 | 311.78M |
| 409 | REPL | Replimune Group, Inc. | 743.15M | 3.57% | 10,957,730 | - |
| 410 | ALLO | Allogene Therapeutics, Inc. | 742.08M | -0.92% | 8,548,525 | 22.00K |
| 411 | PHAT | Phathom Pharmaceuticals, Inc. | 733.93M | -3.65% | 1,599,197 | 204.89M |
| 412 | RLMD | Relmada Therapeutics, Inc. | 718.50M | -4.99% | 711,137 | - |
| 413 | SLDB | Solid Biosciences Inc. | 707.85M | -2.04% | 771,023 | - |
| 414 | LMRI | Lumexa Imaging Holdings, Inc. | 706.19M | -5.53% | 585,551 | 1.03B |
| 415 | TENX | Tenax Therapeutics, Inc. | 704.77M | 0.84% | 1,700,382 | - |
| 416 | ANRO | Alto Neuroscience, Inc. | 694.04M | -1.35% | 219,426 | - |
| 417 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 684.92M | -4.68% | 187,932 | - |
| 418 | ZVRA | Zevra Therapeutics, Inc. | 679.23M | -0.86% | 2,054,860 | 122.29M |
| 419 | CBLL | CeriBell, Inc. | 668.17M | -4.55% | 384,312 | 95.07M |
| 420 | CRMD | CorMedix Inc. | 662.92M | 0.12% | 1,196,535 | 400.05M |
| 421 | BVS | Bioventus Inc. | 662.43M | -6.82% | 866,752 | 576.30M |
| 422 | PHR | Phreesia, Inc. | 658.91M | 8.11% | 2,207,521 | 495.59M |
| 423 | CBIO | Crescent Biopharma, Inc. | 655.28M | -4.50% | 423,414 | 11.88M |
| 424 | TLRY | Tilray Brands, Inc. | 654.86M | -0.36% | 3,321,347 | 858.28M |
| 425 | DSGN | Design Therapeutics, Inc. | 652.05M | -0.38% | 1,522,332 | - |
| 426 | IMMX | Immix Biopharma, Inc. | 643.47M | 2.44% | 1,193,150 | - |
| 427 | CSTL | Castle Biosciences, Inc. | 636.02M | -0.52% | 312,139 | 339.92M |
| 428 | TRAX | First Tracks Biotherapeutics, Inc. | 631.20M | 13.35% | 854,741 | - |
| 429 | CADL | Candel Therapeutics, Inc. | 623.53M | 2.53% | 1,629,528 | - |
| 430 | SIBN | SI-BONE, Inc. | 615.12M | -1.63% | 763,188 | 206.22M |
| 431 | PRME | Prime Medicine, Inc. | 614.10M | -4.23% | 2,493,833 | 4.03M |
| 432 | SGP | SpyGlass Pharma, Inc. | 612.37M | -4.88% | 44,736 | - |
| 433 | BWAY | BrainsWay Ltd. | 611.31M | -2.83% | 160,478 | 56.22M |
| 434 | ACRS | Aclaris Therapeutics, Inc. | 606.14M | -4.62% | 2,228,408 | 8.37M |
| 435 | CABA | Cabaletta Bio, Inc. | 598.41M | -2.91% | 2,714,554 | - |
| 436 | DNA | Ginkgo Bioworks Holdings, Inc. | 597.07M | -2.45% | 1,080,343 | 151.40M |
| 437 | ALT | Altimmune, Inc. | 585.37M | -1.31% | 2,294,436 | 36.00K |
| 438 | EIKN | Eikon Therapeutics, Inc. | 584.16M | -0.46% | 213,092 | - |
| 439 | BBNX | Beta Bionics, Inc. | 570.39M | 5.61% | 707,003 | 110.24M |
| 440 | IRWD | Ironwood Pharmaceuticals, Inc. | 569.56M | -3.08% | 1,699,525 | 361.51M |
| 441 | CERS | Cerus Corporation | 569.05M | -6.58% | 2,558,393 | 216.56M |
| 442 | CLYM | Climb Bio, Inc. | 563.67M | 7.66% | 2,482,155 | - |
| 443 | AGMB | AgomAb Therapeutics NV | 563.40M | 1.69% | 31,529 | - |
| 444 | NPCE | NeuroPace, Inc. | 562.89M | -0.18% | 169,989 | 99.53M |
| 445 | PROK | ProKidney Corp. | 558.81M | 1.09% | 1,467,083 | 889.00K |
| 446 | ARVN | Arvinas, Inc. | 553.59M | -4.45% | 794,230 | 89.40M |
| 447 | RIGL | Rigel Pharmaceuticals, Inc. | 552.47M | -2.07% | 363,948 | 299.77M |
| 448 | VALN | Valneva SE | 552.39M | -4.80% | 57,745 | 180.25M |
| 449 | CTKB | Cytek Biosciences, Inc. | 547.56M | 1.19% | 774,604 | 204.17M |
| 450 | TECX | Tectonic Therapeutic, Inc. | 545.13M | -7.31% | 157,448 | - |
| 451 | ACHV | Achieve Life Sciences, Inc. | 544.09M | 1.15% | 1,547,341 | - |
| 452 | TCMD | Tactile Systems Technology, Inc. | 540.90M | -2.56% | 421,951 | 343.52M |
| 453 | ASMB | Assembly Biosciences, Inc. | 533.48M | -2.68% | 219,019 | 71.10M |
| 454 | MDXG | MiMedx Group, Inc. | 533.23M | -2.72% | 1,396,500 | 389.42M |
| 455 | GYRE | Gyre Therapeutics, Inc. | 530.87M | -1.69% | 125,475 | 117.05M |
| 456 | SRTA | Strata Critical Medical, Inc. | 529.54M | -3.01% | 798,070 | 228.58M |
| 457 | XOMA | XOMA Royalty Corporation | 522.84M | -0.05% | 119,259 | 48.56M |
| 458 | WEAV | Weave Communications, Inc. | 515.59M | 7.64% | 1,555,848 | 248.72M |
| 459 | FLGT | Fulgent Genetics, Inc. | 513.77M | -0.28% | 514,167 | 320.35M |
| 460 | EDIT | Editas Medicine, Inc. | 512.56M | -3.47% | 3,101,719 | 38.69M |
| 461 | FDMT | 4D Molecular Therapeutics, Inc. | 507.60M | -2.02% | 1,075,280 | 88.24M |
| 462 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 463 | PRTA | Prothena Corporation plc | 502.07M | -5.80% | 457,810 | 57.94M |
| 464 | AQST | Aquestive Therapeutics, Inc. | 501.80M | -0.50% | 1,413,035 | 50.27M |
| 465 | KYTX | Kyverna Therapeutics, Inc. | 497.56M | -3.52% | 671,726 | - |
| 466 | PACB | Pacific Biosciences of California, Inc. | 490.75M | 6.04% | 8,207,767 | 160.03M |
| 467 | AUTL | Autolus Therapeutics plc | 489.70M | -1.60% | 1,531,265 | 92.62M |
| 468 | CTNM | Contineum Therapeutics, Inc. | 489.39M | -2.97% | 130,689 | - |
| 469 | CCCC | C4 Therapeutics, Inc. | 482.59M | 0.23% | 3,774,559 | 34.86M |
| 470 | ANL | Adlai Nortye Ltd. | 481.20M | 0.75% | 151,606 | 5.00M |
| 471 | TOI | The Oncology Institute, Inc. | 477.92M | 1.92% | 1,400,336 | 545.76M |
| 472 | OVID | Ovid Therapeutics Inc. | 477.80M | -6.23% | 1,980,928 | 7.12M |
| 473 | FBRX | Forte Biosciences, Inc. | 470.14M | 0.89% | 354,841 | - |
| 474 | EVH | Evolent Health, Inc. | 469.05M | 5.57% | 2,869,866 | 1.89B |
| 475 | STRO | Sutro Biopharma, Inc. | 468.11M | -3.35% | 216,244 | 99.61M |
| 476 | OCGN | Ocugen, Inc. | 463.77M | -0.72% | 5,571,496 | 4.47M |
| 477 | CTEV | Claritev Corporation | 460.12M | 7.44% | 152,059 | 978.76M |
| 478 | NRC | NRC Health | 456.37M | 3.69% | 190,178 | 138.64M |
| 479 | ANGO | AngioDynamics, Inc. | 454.75M | -4.97% | 370,953 | 313.73M |
| 480 | EPRX | Eupraxia Pharmaceuticals Inc. | 452.03M | -3.24% | 254,271 | - |
| 481 | LAB | Standard BioTools Inc. | 448.92M | - | 2,375,615 | 86.26M |
| 482 | MOBI | Mobia Medical, Inc. | 446.65M | 3.05% | 108,523 | 32.04M |
| 483 | KMDA | Kamada Ltd. | 446.18M | -1.41% | 50,084 | 181.68M |
| 484 | SGMT | Sagimet Biosciences Inc. | 444.00M | -1.37% | 736,573 | - |
| 485 | UPB | Upstream Bio, Inc. | 439.71M | -3.35% | 595,102 | 3.32M |
| 486 | EBS | Emergent BioSolutions Inc. | 438.05M | -6.91% | 852,283 | 676.80M |
| 487 | NGNE | Neurogene Inc. | 435.18M | -2.82% | 102,355 | 925.00K |
| 488 | STTK | Shattuck Labs, Inc. | 433.24M | -5.04% | 714,003 | 1.00M |
| 489 | ADCT | ADC Therapeutics SA | 432.45M | - | 620,445 | 79.18M |
| 490 | MNPR | Monopar Therapeutics Inc. | 431.40M | -0.98% | 92,886 | - |
| 491 | EOLS | Evolus, Inc. | 429.37M | -0.61% | 874,413 | 301.79M |
| 492 | FULC | Fulcrum Therapeutics, Inc. | 427.79M | -7.23% | 3,121,467 | 80.00M |
| 493 | KIDS | OrthoPediatrics Corp. | 427.66M | -3.03% | 174,371 | 243.30M |
| 494 | VTVT | vTv Therapeutics Inc. | 425.65M | 2.85% | 59,613 | 36.84M |
| 495 | IPSC | Century Therapeutics, Inc. | 425.64M | -3.67% | 910,310 | 109.16M |
| 496 | VREX | Varex Imaging Corporation | 422.73M | -1.96% | 403,250 | 857.50M |
| 497 | GLSI | Greenwich LifeSciences, Inc. | 418.48M | 8.90% | 224,597 | - |
| 498 | CATX | Perspective Therapeutics, Inc. | 417.41M | -7.11% | 1,479,031 | 618.00K |
| 499 | CGC | Canopy Growth Corporation | 413.02M | -0.92% | 5,176,473 | 203.04M |
| 500 | CCRN | Cross Country Healthcare, Inc. | 405.90M | - | 579,729 | 1.00B |